Moran Wealth Management, LLC Astrazeneca PLC Transaction History

Moran Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $91,239 - $104,007	1,495 Added 3.02%	50,995 $3.45 Million
Q4 2023 Feb 07, 2024	BUY	$61.89 - $69.28 $1.12 Million - $1.25 Million	18,045 Added 57.37%	49,500 $3.33 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $7,911 - $8,747	122 Added 0.39%	31,455 $2.13 Million
Q2 2023 Aug 10, 2023	SELL	$69.91 - $75.81 $31,669 - $34,341	-453 Reduced 1.43%	31,333 $2.24 Million
Q1 2023 May 10, 2023	SELL	$63.15 - $71.6 $35,742 - $40,525	-566 Reduced 1.75%	31,786 $2.21 Million
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $1.75 Million - $2.28 Million	32,352 New	32,352 $0

1,343

492M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Moran Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Moran Wealth Management, LLC with notifications on news.